Alios BioPharma attracts $41 mln
Alios BioPharma has closed $41 million in Series B financing. Investors included Novo Ventures, SR One, Roche Venture Fund and Novartis Ventures. Based in South San Francisco, Alios BioPharma is a biotech firm focused on respiratory viral diseases.
8 April 2014•2 mins read
